EP 1183349 A1 20020306 - TUMOR-ASSOCIATED ANTIGEN (C42)
Title (en)
TUMOR-ASSOCIATED ANTIGEN (C42)
Title (de)
TUMORASSOZIIERTES ANTIGEN (C42)
Title (fr)
ANTIGENE SPECIFIQUE DE TUMEUR (C42)
Publication
Application
Priority
- DE 19924199 A 19990527
- EP 0004533 W 20000519
Abstract (en)
[origin: DE19924199A1] The invention relates to a tumor-associated antigen, to immunogenic peptides derived therefrom, to coding DNA molecules that code therefor, and to their use in the immune based therapy of cancer diseases.
IPC 1-7
IPC 8 full level
G01N 33/48 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07K 14/47 (2006.01); C07K 16/30 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/08 (2006.01); G01N 33/53 (2006.01)
CPC (source: EP)
A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07K 14/4748 (2013.01); A61K 39/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5152 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/53 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DE 19924199 A1 20001130; AR 024114 A1 20020904; AU 4924000 A 20001218; CA 2376133 A1 20001207; CO 5280140 A1 20030530; EP 1183349 A1 20020306; JP 2003501025 A 20030114; MX PA01012012 A 20020621; UY 26170 A1 20001229; WO 0073438 A1 20001207
DOCDB simple family (application)
DE 19924199 A 19990527; AR P000102577 A 20000526; AU 4924000 A 20000519; CA 2376133 A 20000519; CO 00038722 A 20000525; EP 0004533 W 20000519; EP 00931244 A 20000519; JP 2001500751 A 20000519; MX PA01012012 A 20000519; UY 26170 A 20000526